InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (15 oper.)
Historial del iniciado
Director FinancieroCompras declaradas
0
Ventas declaradas
15
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Chopas James George, VP/Chief Accounting Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 30 disclosures have been published. Breakdown: 0 buy · 15 sells. Total volume traded: €289k. Activity tracked since 30 August 2021. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Chopas James George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones30 en total
65.955 títulosCommon StockSEC:0001193125-26-224627:0
16.150 títulos0Common StockSEC:0001492422-26-000078:0
2064 títulos@ 21,7654 US$10.3% de su flujoCommon StockSEC:0001492422-26-000060:0
726 títulos@ 19,7929 US$3.3% de su flujoCommon StockSEC:0001492422-26-000044:0
873 títulos@ 22,1872 US$4.4% de su flujoCommon StockSEC:0001492422-26-000031:0
189 títulos@ 24,192 US$1.3% de su flujoCommon StockSEC:0001492422-25-000005:0
548 títulos@ 28,077 US$4.4% de su flujoCommon StockSEC:0001127602-25-021110:0
6250 títulos0Common StockSEC:0001127602-25-017836:0
183 títulos@ 24,8237 US$1.4% de su flujoCommon StockSEC:0001127602-25-009738:0
1096 títulos@ 30,4255 US$11.1% de su flujoCommon StockSEC:0001127602-25-001829:0
715 títulos@ 29,9582 US$7.2% de su flujoCommon StockSEC:0001127602-25-001614:0
12.591 títulos0Common StockSEC:0001127602-25-001614:1
783 títulos@ 28,7021 US$7.6% de su flujoCommon StockSEC:0001127602-25-001184:0
192 títulos@ 36,206 US$2.2% de su flujoCommon StockSEC:0001127602-24-024074:0
550 títulos@ 39,491 US$6.8% de su flujoCommon StockSEC:0001127602-24-023392:0
184 títulos@ 56,461 US$3.3% de su flujoCommon StockSEC:0001127602-24-010416:0
1061 títulos@ 64,996 US$21.9% de su flujoCommon StockSEC:0001127602-24-001928:0
8312 títulos0Common StockSEC:0001127602-24-001441:0
132 títulos@ 46,0362 US$2.0% de su flujoCommon StockSEC:0001127602-23-026188:0
2500 títulos0Common StockSEC:0001127602-23-024308:0
551 títulos@ 41,226 US$7.2% de su flujoCommon StockSEC:0001127602-23-023568:0
4044 títulos0Common StockSEC:0000899243-23-005785:0
919 títulos@ 52,05 US$15.3% de su flujoCommon StockSEC:0001127602-23-002111:0
9621 títulos0Common StockSEC:0001127602-23-001491:0
130 títulos@ 58,00 US$2.7% de su flujoCommon StockSEC:0001127602-22-024299:0
25 de 30 declaraciones
About Chopas James George
Chopas James George is VP/Chief Accounting Officer at Apellis Pharmaceuticals, Inc. He has 30 filings in total, and in the sampled recent filings from 2021-09-01 to 2026-05-14, sales total 288897 EUR, with the modal transaction nature listed as sale.
